Rare diseases
Investigational molecules
Locations
Back to Romania12 clinical trials in Campulung, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)RomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaRomaniaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive investigation of novel treatments for relapsing multiple sclerosis (RMS), featuring comparative studies of innovative therapies like frexalimab and remibrutinib against established treatments.
Multiple ongoing trials focusing on reducing relapse frequency and improving patient outcomes.
Dedicated research into primary progressive multiple sclerosis (PPMS), evaluating breakthrough treatments including BTK inhibitors and specialized therapies for disease progression.
Innovative approaches to addressing the unique challenges of progressive MS forms.
Broader research portfolio including studies on migraine prevention and various nervous system conditions, with trials evaluating new therapeutic approaches for treatment-resistant cases.
Focus on developing solutions for patients who haven't responded to conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
